New Hampshire Hospice and Palliative Care Organization
125 Airport Rd, Concord, NH 03301    603-225-0900   info@nhhpco.org

... improving access to quality care for New Hampshire residents with life-threatening conditions

 What's New  NH Providers  Notices NH Pain Initiative Membership  Info    Contact Info  
About NHHPCO
About Hospice &   Palliative Care
Hospice & Palliative Care Providers and Hospice House Facilities
How to Join or Renew Membership
How to Make a Donation

Outcome Measures

Networking Meetings
Best Practices
Resources
Education Events and  Conferences
NHHPCO Fall Conference
Advance Directives
NH Pain Initiative
Golf Tournament

Newsletter

Notices
Employment
Contact Info

Opioid Use Guidelines

ORDERING Information and ORDER FORM available HERE
 

  Ordering Information
Regression Equation
References
Adjuvants

 

The following Opioid Use Guidelines have been prepared by the NHHPCO Palliative Care Clinicians Special Interest Group as part of their 'Best Practices Project'. 

Please Note: This information was produced as a guide ONLY. All doses and recommendations should be checked and verified by an experienced provider prior to use. The authors assume no responsibility for its use.

Table 1:   Equianalgesic  Dosing

Drug

Initial (IR)  Dose PO

Peds dose:
(IR) initial /  kg

PO:IV

PO MS : Drug PO

Drug PO :
PO MS

Morphine (MS)

15 mg

0.1 - 0.3 mg/kg

3 : 1

1 : 1

1 : 1

Hydromorphone (HM)

2 or 4mg

0.06 mg/kg

4 : 1

1 : 0.25

1 : 4

Oxycodone (Oxy)

5 or 10mg

0.2 mg/kg

n/a

1 : 0.66

1 : 1.5

Methadone (Me)

2.5 or 5mg

0.1 mg/kg

2 : 1

See below

See below

Fentanyl Transderm (TDF) / SC / IV

10 - 25 mcg/hr

1 mcg/kg/hr

n/a

See below shortcut

See below shortcut

* Patients on codeine and hydrocodone can be treated as opioid naïve.

Steps to Rotate or Change Opioids
1. Calculate 24 hr dose of current drug.
2. Translate that to equianalgesic 24 hr dose of oral morphine.
3. Calculate 24 hr equianalgesic dose of new drug and
reduce dose to 50-75% of calculated dose if pain is well controlled; use 100% otherwise.
4. Divide to attain appropriate interval and dose for new drug.
5. Always have breakthrough dosing available while making changes.

Breakthrough Dosing (immediate release (IR) / short acting meds only)
50-150% of IV basal dose q15 minutes  OR  10-20% of 24 hr oral dose q1hr.

Changing Basal Rates  (due to inadequate baseline pain control)
Increase rate by 50-100% of IV basal rate q15 minutes.
Give a breakthrough dose each time basal rate is increased. 

Ceiling Effect = uncontrollable pain with appropriate increases in dose  OR side effects such as neuroexcitation, myoclonus, or protracted central effects. 
a) Rotate to another opioid as above.
b) Dose reduce opioid by 25-50% with addition of other treatment for pain.
c) Treat side effect +/- dose reduce.

Partial Reversal with Naloxone: ONLY for overdose in rare cases:
à mix 0.4 mg amp with saline to make 10cc + administer 0.5 -1 ml (0.02-0.04 mg) IV/SC q2-5 minutes until response; naloxone effect shorter in duration than long acting opioids and close monitoring +/- repeat doses sometimes necessary.


Table 2:  MS : Me
 

One Way Rotation from PO Morphine ( MS) to PO Methadone (Me)

 4 : 1   for up to 100mg MS

15 : 1  for  501 - 1000 mg MS
 8 : 1   for 101 - 300 mg MS 20 : 1  for  > 1000 mg MS
 12 : 1  for 301 - 500 mg MS  

METHADONE
CAUTION: Use only with experience or training in pain mgt.
- Dosing interval is titrated for analgesic effect q4-12h; start with q8h.
- Delayed side effects @ Day 4 after initiation: highly lipid soluble with potential delayed and prolonged side effects that outlast analgesic efficacy.
- Prolonged QT at high dose>200 mg/day; interactions at CYP450 (esp 2D6, 3A4)
- Common drugs that increase methadone effect: SSRI’s (fluoxetine), TCA’s (amitriptyline), macrolides, metronidazole, grapefruit juice.
- Decrease methadone effect: antiretrovirals, carbamazepine, rifampin, phenytoin.

Rotation to Methadone 
Day  1: Calculate dose (above).  Give 33% methadone dose + 66% of present drug.
Day  2: Give 66% methadone dose + 33%  present drug.
Day  3: Give 100% methadone dose.

Rotation from Methadone
Caution: Ratios above do not necessarily apply consult an expert.

Rotating to and from Transdermal Fentanyl (TDF)
Shortcut: Transdermal Fentanyl (mcg/hr) X 2 = approx 24 hr dose of MS PO(mg).
From TDF: Start new drug at 50% dose for 6-24 hrs after removal of TDF. 
To TDF: Continue old drug at 50% dose for 6-24 hrs after starting TDF.

Bowel Routine
All patients on opioids should be on a baseline bowel routine such as one or more of the following:
à Senna + docusate (Senokot S) 1-2 tabs twice daily.
à MOM 30-60 cc twice to three times daily.
à Lactulose  30-60 cc twice to three times daily.
à PEG solution: Miralax 1-4 T daily or 4-8 oz of GoLytely titrated to effect.

STEP UP: If symptoms of constipation, lack of BM for specified period of time, or risk factors present such as immobilization, hospitalization, significant increase in opioids:
à Double dose of regimen above  OR  add 2nd agent such as Lactulose or Miralax.

RECTAL  IMPACTION
 or significant rectal stool: Empty rectum first with:
à Bisacodyl 10 mg pr bid for 1-3 days or Fleet or other enemas until clear. Then 
proceed with stepped up bowel regimen as above.     


REGRESSION EQUATION

Repetitive research (see references below) shows that equianalgesic ratios between methadone and morphine are dose dependent and vary depending on dose.  Studies show relationships that vary considerably with the most conservative ratio listed above in Table 2 (Ms : Me).  Intuitively the variation in ratio occurs gradually, not at sudden intervals.  

A regression equation can be derived that estimates the relationship based on gradual change in ratio. Below is one regression equation derived from slightly more aggressive ratios than in table 2.
Please use with caution.

Special thanks  to Louis Gallerani for deriving the equation and plotting the graph.
 


REFERENCES

Main reference:
Quigley C. Opioid Switching to improve pain relief and drug tolerability. Cochrane Review,  2004, Issue 3, pg1-34  (
everyone should have this comprehensive review and use it to access primary literature)


Additional references:

Pereira J et al. Equianalgesic Dose ratios for Opioids: a critical review and proposals for long term dosing.  J of Pain and Symp Mgt, 22(2), August 2001, pg 672-687

Benitez-Rosario MA et al. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer, 2004, Dec 15;101(12):2866-72

Kornick CA et al. A safe and effective method for converting cancer patients from IV to TD fentanyl.  Cancer, 2001,  Dec 15; 92(12):3056-61


Equianalgesic cards and tables:

UpToDate www.uptodate.com
The Prescriber’s Letter www.fhea.com/prescribers_newsletter_request.htm
Life’s End Institute www.lifes-end.org
Partners Against Pain www.partnersagainstpain.com
GlobalRPH.com www.GlobalRPH.com
PainCare.ca www.PainCare.ca
Northwestern Memorial Hospital Pain Mgt Card www.nmh.org
Bedside Pain Manager, Judi Hunt RN www.bedsidepainmanager.com

ADJUVANT THERAPIES FOR PAIN

Bone Pain
NSAIDS, steroids, calcitonin, bisphosphonates

- ibuprofen 600 mg every 6 hours
(no NSAID has been proven any more effective than any other in large studies though individual responses vary)
- if one NSAID does not work, try another in a different class

Neuropathic Pain
gabapentin, TCA’s, topical anesthetics
- gabapentin 100 mg po tid rapidly escalating to up to 4800 mg/d
- desipramine 10-25 mg po qhs up to 100 mg po qhs
- transdermal lidocaine 5% applied as needed
- compounded mixes (ie ketamine 5-10%; amitriptylline 2-5%; ketoprofen 10-20%; baclofen 2-10%)

Muscle Spasm
- baclofen 5-20 mg 2-4 times per day up to 60 mg/day
- tizanidine 2-8 mg tid up to 36 mg/day

Tramadol 50-100 mg tid

Also
Cognitive Behavioral Therapy
Physical treatments (heat, cold, splinting)
Sensual Therapy (art, music, touch, aromatherapy)
Spiritual assessment and treatment


Pocket Cards Available

This information is available on plastic laminated Pocket Cards directly from the New Hampshire Hospice and Palliative Care Organization.
ORDERING Information and ORDER FORM available HERE.


Please Note: The foregoing information was produced as a guide ONLY. All doses and recommendations should be checked and verified by an experienced provider prior to use. The authors assume no responsibility for its use.

  5 BACK TO TOP
 

This NHHPCO website is designed and maintained entirely through volunteered services.
© 2005-2008 New Hampshire Hospice and Palliative Care Organization
 

Home | About H & PC | About NHHPCO | NH Providers | NHHPCO Members | Employment | Networking  Meetings
 
How to Make a Donation | Advance Directives | Outcome Measures | Resources  

 What's New | How to Join | How  to Renew MembershipEducational Events
Pain Initiative | Golf Tournament
Notices |  Newsletter | Contact Info